Idhifa
Payments companies reported to CMS as associated with Idhifa. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Idhifa, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Idhifa
These are the largest totals companies reported as associated with Idhifa. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Edward Pearson | Dallas, TX | Hematology & Oncology | $1,281.34 |
| Daryl Kurozawa | Kailua Kona, HI | Surgery | $124.49 |
| Sanam Loghavi | Houston, TX | Anatomic Pathology & Clinical Pathology | $104.73 |
| Tondre Buck | Spartanburg, SC | Hematology & Oncology | $97.30 |
| Gabriel Domenech | Plantation, FL | Hematology & Oncology | $96.67 |
| Stevie Camp | Miami Beach, FL | Family | $91.82 |
| Anna Wagner | Corpus Christi, TX | Family | $85.25 |
| Rachael Harmon | Daphne, AL | Radiation Oncology | $84.16 |
| Haider Khadim | Syracuse, NY | Medical Oncology | $82.43 |
| Natalie Tafel | New York, NY | Physician Assistant | $81.17 |
Prescribed Idhifa?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.